Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sipai Health Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 514.26%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sipai Health Technology Co's 3-Year ROIIC % or its related term are showing as below:
FRA:AX1's 3-Year ROIIC % is ranked better than 99.12% of 113
companies
in the Medical Distribution industry
Industry Median: 3.27
vs FRA:AX1: 514.26
Sipai Health Technology Co (FRA:AX1) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sipai Health Technology Co 3-Year ROIIC % Related Terms
Sipai Health Technology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AX1 vs MCK, COR, CAH: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, Sipai Health Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -11.0752135 (Dec. 2025) - -83.003 (Dec. 2022) )
/
( 82.625 (Dec. 2025) - 77.519 (Dec. 2022) )
=
71.9277865
/
5.106
=
1,408.69%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sipai Health Technology Co (FRA:AX1) has a 3-Year ROIIC % of 514.26 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sipai Health Technology Co and its competitors. According to the industry distribution chart, Sipai Health Technology Co ranks #1 out of 113 companies in the Medical Distribution industry, placing it in the top 0.90000000000001%.
Is Sipai Health Technology Co's 3-Year ROIIC % too high?
Sipai Health Technology Co's current 3-Year ROIIC % is 514.26. The Medical Distribution industry median 3-Year ROIIC % is 3.27. Sipai Health Technology Co's value of 514.26 is 15626.6% above this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #1 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sipai Health Technology Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's 3-Year ROIIC % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #1 out of 113 companies for 3-Year ROIIC %. This places Sipai Health Technology Co in the top 1% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.27. Sipai Health Technology Co's value of 514.26 is 15626.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 3.27, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current 3-Year ROIIC % of 514.26 is 15626.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 3.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current 3-Year ROIIC % is 514.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current 3-Year ROIIC % of 514.26. The stock's GF Value™ is €0.22, compared to a current price of €0.14 — trading 36.8% below its estimated fair value. The current 3-Year ROIIC % is 514.26 and 15626.6% above the Medical Distribution industry median of 3.27. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current 3-Year ROIIC % is 514.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of €0.14 is trading 36.8% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:AX1:
3-Year ROIIC %: 514.26
GF Value™: €0.22 vs. price of €0.14 (36.8% below fair value)
Industry Position: 15626.6% above the Medical Distribution median (#1 of 113)
No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for FRA:AX1
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AX1 has been successfully added to your 
